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In this series of 31 patients with acute infection due to human immunodeficiency virus (HIV)
type 1, the male-to-female ratio was 3.4:1 and the mean age was 31.3 years. Sexual transmission
accounted for 83.9% of cases; 45.2% of the patients were homosexual and 38.7% were heterosex-
ual. The mean duration of symptoms and signs was 21 days (range, 5-60 days). Fever (87.1%)
and skin rash (67.7%) were most commonly reported. Physical examination findings were abnor-
mal for 96% of the patients; the oral cavity (76.7%) and the skin (73.3%) were the most fre-
quently involved sites. Thirteen of 25 patients with sexually acquired infection had genital or oral
ulcers, whereas five intravenous drug users had none (P = .052). Thrombocytopenia was the most
common hematologic abnormality and was detected in 17 of 23 patients tested. P24 antigene-
mia, an initially negative screening test for HIV antibody, and a low CD4+ lymphocyte count
were noted in 23 of 29, 23 of 30, and 14 of 21 tested patients, respectively.
Clinical symptoms and signs of primary infection due to
human immunodeficiency virus type 1 (HIV-1) were first
described at the end of 1984 in regard to a nurse who was
accidentally infected by a needlestick [1]. A few months
later, a review of 12 cases by Cooper et al. [2] emphasized a
mononucleosis-like illness with a rapid onset as the main
manifestation of the acute infectious stage. Since then, a
number of case reports and reports of small series have
shown an ever-evolving spectrum of clinical manifestations
such as mucocutaneous lesions, odynophagia, lymphadenop-
athy, splenomegaly, nausea, vomiting, diarrhea, arthralgia,
myalgia, headache, retroorbital pain, and neurological syn-
dromes. The latter include serious conditions such as vascu-
litis, aplastic anemia, esophageal candidiasis, hepatitis, spon-
taneous rupture of the spleen, pneumonitis with respiratory
failure, renal involvement, and rhabdomyolysis [3-18].
The clinical illness is generally self-limited, although rapid
progression toward AIDS has been described [19]. Some au-
thors have suggested that long-lasting and severe symptoms
might have a negative effect on long-term prognosis and that
treatment should be considered even at this very early stage
of infection [20-22]. Early recognition of the primary HIV
infection syndrome is of obvious importance, not only in
terms of medical counseling and prevention of further dis-
ease transmission by infected patients but also because early
treatment may potentially improve the long-term clinical
outcome [22, 23].
Received 14 September 1992; revised 28 December 1992.
Financial support: The Swiss National Programme for AIDS Research.
Reprints or correspondence: Dr. L. H. Perrin, Central Laboratory of Virol-
ogy, University Cantonal Hospital, CH-1211 Geneva 14, Switzerland.
Clinical Infectious Diseases 1993;17:59-65
© 1993 by The University of Chicago. All rights reserved.
1058-4838/93/1701-0010$02.00
The present study analyzes the epidemiological, clinical,
and laboratory data from a series of cases of symptomatic
primary HIV infection. Our hospital is located in an area
where medical care is easily accessible and the incidence of
HIV infection is high [24]. It has an active outpatient care
department and an affiliation with general practitioners;
such circumstances should favor frequent recognition of pri-
mary HIV infection and permit the assessment of the relative
importance of symptoms and signs.
Patients and Methods
Patients. Data concerning all the patients tested for HIV
antibodies from May 1988 to May 1991 in the Central Labo-
ratory of Virology at the Geneva University Hospital were
reviewed for evidence of seroconversion. This facility acts as
a reference laboratory for HIV serological testing in the Ge-
neva area. We collected data from a total of 16 cases and
prospectively included data from another 17 that were diag-
nosed from June 1991 to April 1992. Medical files of the 35
patients were reviewed for evidence of an illness at the time
of seroconversion. The following data were recorded from
the files: sex, age, risk factors, clinical symptoms and signs,
the need for hospital admission, duration of hospitalization,
and laboratory parameters (i.e., complete blood cell count
[CBC], HIV serology, and lymphocyte subset counts).
Patients were included in the study if (1) they had a clini-
cally evident illness at the time laboratory tests revealed HIV
seroconversion and (2) they had p24 antigenemia and/or the
results of an HIV antibody screening assay at presentation
were negative or barely positive (optical density, <1.000)
but evidence of seroconversion was subsequently revealed
on western blotting. Patients without p24 antigenemia were
included only if the HIV antibody screening test had been
negative in the recent past (within the previous 6 months).
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Table 1. Characteristics of the study population of patients presenting with symptomatic primary
HIV-1 infection (n = 31).
Variable Male Female Total
No. (%) of patients 24 (77.4) 7 (22.6) 31 (100)
Mean age, y (range) 32.3 (21.0-54.7) 27.8 (21.8-33.3) 31.3 (21.0-54.7)
No. (%) of patients with risk factor
Homosexual contacts 14 (45.2) 0 14 (45.2)
Heterosexual contacts 7 (22.6) 5 (16.1) 12 (38.7)
Intravenous drug abuse 3 (9.7) 1 (3.2) 4 (12.9)
Health care workers 0 1 (3.2) 1 (3.2)
No. (%) of patients admitted to
hospital 10 (32.3) 3 (9.7) 13 (41.9)
Mean length of stay, d (range) 9.5 (3-16) 12.7 (7-16) 10.2 (3-16)
Mean duration of illness, d (range) 22.9 (5-60) 14.0 (5-21) 21 (5-60)
For two patients who seroconverted, HIV serologies (p24
antigen and HIV antibody screening tests) were negative at
the first medical visit.
Clinical assessment. The clinical symptoms and signs re-
corded were those reported by the patients at their first medi-
cal consultation and those noted during subsequent visits
until complete resolution of the illness. The patients
enrolled were first seen at the local university hospital as
outpatients in the emergency department (n = 11) or in the
dermatology (n = 5) or medical (n = 5) outpatient clinic or
were recruited via their primary care physicians (n = 10). A
number of them were admitted to the dermatology (n = 6),
medical (n = 6), or surgical (n = 1) wards for diagnosis and/
or treatment.
Laboratory investigations. Serologies for HIV included
an antibody screening test (HIV1/HIV2 EIA, Abbott Labora-
tories, North Chicago, IL), a western blot analysis (Biotech/
Dupont, Geneva), and a p24 antigen test (HIVAG-1, Ab-
bott). Positive p24 antigen tests were all neutralized
according to the manufacturer's guidelines. The CD4 and
CD8 lymphocyte counts were determined with use of stan-
dard methods, i.e., with monoclonal antibodies (Ortho Diag-
nostic System, Raritan, NJ) and flow cytometry (Coulter
EPICS IV, Instrumente Gesellschaft AG, Zurich).
Laboratory results were retained for analysis only if the
tests had been performed on samples obtained within 1 week
(for CBC and HIV serology) or 2 weeks (for lymphocyte sub-
set determination) of the first consultation.
Results
Thirty-one of 35 patients for whom HIV seroconversion
was proved by laboratory tests fulfilled the selected criteria
for inclusion in the study; the other four did not have clinical
illness at the time of seroconversion and were therefore ex-
cluded. Table 1 shows the demographic characteristics of the
study group. The male-to-female ratio was 3.4:1, and the
majority of patients were young adults. HIV infection was
sexually acquired by 26 patients (83.9%) and that of the re-
maining five (16.1%) was due to parenteral exposure (four of
the five were intravenous drug users [IVDUs] and one was a
health care worker). The rate of hospital admission for diag-
nosis and treatment was high (42%). For 28 patients for
whom data were sufficient, the duration of clinical symptoms
was as follows: <1 week for 3 patients (10.7%), 1-2 weeks for
7 (25%), 2-3 weeks for 8 (28.6%), 3-4 weeks for 4 (14.3%),
and >4 weeks for 6 (21.4%).
Table 2 summarizes the recorded physical complaints.
Fever and a skin rash were the most common symptoms. A
flulike illness was noted in almost one-half of the patients.
However, involvement of the tracheobronchial tree or of the
abdomen was a common feature as well. Serious CNS com-
plaints, such as meningismus (n = 2) and hallucinations (n =
Table 2. Symptoms reported at the time of the first medical visit
by 31 patients with primary HIV-1 infection.
Symptom No. (%) of patients
Fever 27 (87.1)
Skin rash 21 (67.7)











Weight loss 4 (12.9)
Oral ulcers 4 (12.9)
Other* 15 (48.4)
* Other symptoms included: chest pain (n = 2), meningismus (n = 2),
vaginal discharge (n = 2), urethritis (n = 2), swollen glands (n = 2), genital
ulcers (n = 2), yellow sputum (n = 1), night sweats (n = 1), and melena
(n = 1).
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Table 3. Anatomic sites involved in 30 patients with abnormal
physical signs.
Site affected No. (%) of patients
Skin 22 (73.3)
Oral cavity 23 (76.7)
Lymph nodes 17 (56.7)
Lungs 4 (13.3)
Abdomen and gastrointestinal tract 10 (33.3)
Genitalia 11 (36.6)
Nervous system 4 (13.3)
1), were noted in two patients only. Other symptoms in-
cluded swollen glands (n = 2), chest pain (n = 2), vaginal
discharge (n = 2), genital ulcers (n = 2), urethritis (n = 2),
night sweats (n = 1), yellow sputum (n = 1), melena (n = 1),
and dark urine (n = 1).
Results of physical examinations are shown in Table 3.
Among the 31 patients who reported symptoms, 30 had phys-
ical abnormalities when they were first examined. Fever, der-
matologic lesions, and lymphadenopathy were the most fre-
quent findings. However, systemic physical examination,
particularly that of the genitalia and abdomen, revealed diag-
nostic clues for a large proportion of patients.
In the 21 patients with pyrexia (axillary temperature,
>37.5°C), the average temperature was 38.6°C (range,
37.5°C-39.8°C); eight patients had an average temperature
of >39°C. For the 30 patients with physical abnormalities,
findings on the skin included maculopapular rash (n = 19;
63.3%), urticaria (n = 2; 6.7%), perlêche (n = 2, 6.7%), and
ulcerous lesions of the inguinal area (n = 1; 3.3%). The sites
of skin involvement, in order of frequency, were the trunk (n
= 20; 66.7%), the head (n = 14; 46.7%), the lower limbs (n =
13; 43.3%), and the upper limbs (n = 1 1 ; 36.7%).
Examination of the oral cavities of the 30 patients with
physical abnormalities showed ulcerations (n = 12; 40%),
enanthemas (n = 12; 40%), and candidiasis (n = 6; 20%).
Enanthemas or ulcers were the only oral abnormalities in six
(20%) and seven patients (23.3%), respectively. Five patients
(16.7%) had both enanthemas and ulcers. Candidiasis
(proven by the growth of Candida albicans in culture) was
the only oral abnormality in four (13.3%) of these 30 pa-
tients; the other two patients with candidiasis (6.7%) also had
enanthemas and ulcerations.
Genital ulcerations were present in seven (23.3%) of the
30 patients with physical abnormalities. Patients with ure-
thral (n = 2) and vaginal (n = 2) discharges were found to
have gonococcal and candidal infections, respectively. Thir-
teen patients (43%) presented with either oral or genital ulcer-
ations. The pattern of association of these lesions with a skin
rash is illustrated in figure 1. It is interesting that none of the
5 patients with parenterally acquired HIV infection had oral
or genital ulcerations, whereas 13 (52%) of the 25 patients
with sexually acquired HIV infection did (P = .052; Fisher's
exact test).
Lymphadenopathy affected 17 patients and involved, in
order of frequency, the cervical (15 patients), axillary (9),
inguinal (8), and epitrochlear (1) lymph nodes.
Two cases of pneumonitis, both involving IVDUs, were
recorded. Because of poor compliance, a thorough medical
workup could not be completed in these cases. Cough and
fever were noted in both cases and yellow sputum was ob-
served in one. Oral candidiasis was present in both patients.
Chest roentgenographs showed consolidation of their right
lobes (middle and inferior, respectively). Two other patients
without pulmonary symptoms or roentgenographic abnor-
malities had inspiratory crackles and rhonchi, respectively.
None of these four patients required intensive care.
Examination of the abdomen and gastrointestinal tract
showed evidence of esophagitis in three (10%) of the 30 pa-
tients with physical abnormalities. Endoscopy in these three
cases revealed large ulcers with pseudomembrane formation
that wholly or partially involved the esophagus. Candidal
infection was therefore suspected, and treatment with anti-
fungal agents (ketoconazole or fluconazole) resulted in rapid
recovery. A cytological examination that confirmed the pres-
ence of candidal organisms was performed in the one case
associated with prepyloric ulcerations and melena. Profound
immunosuppression with a low CD4 lymphocyte count
(178/0_, and 185/A) was noted in two of these three pa-
tients. Altogether, unusual clinical presentations of primary
HIV infection, such as pneumonitis, esophagitis, and acute
abdominal conditions, were recorded in 10 cases (33.3%).
Meningismus was noted in two patients. Other neurologi-
Figure 1. Pattern of association between skin rash and mouth
and genital ulcerations. The numbers in the circles show how many
patients had particular lesions; seven patients had none.
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Table 4. Findings related to initial complete blood cell count for
23 patients with symptomatic primary HIV-1 infection.
Finding (perinent cell count) No. (%) of patients
Thrombocytopenia (<150 X 10 3/AL) 17 (73.9)
Leukopenia (<4,000/4) 11 (47.8)
Neutropenia (<1,500/4) 8 (34.8)
Lymphopenia (<1,000/4) 7 (30.4)
Increase from normal band form count (>500/AL) 7 (30.4)
Anemia (Hemoglobin, <140 g/L [M]
or <120 g/L [F]) 6 (26.1)
Monocytosis (>800/AL) 2 (8.7)
Leukocytosis (>11,000/4) 1 (4.3)
Thrombocytosis (>350 X 10 3/4) 1 (4.3)
Lymphocytosis (>4,500/4) 0
cal abnormalities included hypoesthesia of the inner side of
the thigh and slowing of mental faculties, which affected one
patient each.
Table 4 shows the initial CBC for 23 patients for whom
this value was available at the time of acute infection. The
mean value of the thrombocyte count was 148,000/mm 3 ,
and thrombocytopenia (n = 17; 73.9%) was the most fre-
quently encountered hematologic abnormality in these 23
patients.
P24 antigen was detected in the blood of 23 (79.3%) of 29
patients tested at a median level of 183.5 ng/L (range, 4
ng/L-47,500 ng/L). The screening test for antibodies to
HIV-1 and HIV-2 was positive (optical density, 0.273-
0.865) for seven (23.3%) of 30 patients tested. For three pa-
tients, p24 antigenemia was associated with a positive HIV
antibody screening test. For two patients, neither of these
two assays was positive. Reactive bands were observed on
the western blot for eight of 27 patients tested. However, the
criteria for positivity of the western blot (i.e., observance of
at least one reactive band in each of the gag, pol, and env
domains) were fulfilled in only four cases; in all of these
cases, the HIV antibody screening test was positive. Thus,
western blotting did not aid in establishing an early diagnosis
for the patients whose HIV antibody screening test was nega-
tive. The initial CD4 lymphocyte count was low (median,
458/4; range, 178/4-1,082/AL) for 14 (66.7%) of 21 pa-
tients tested. The CD8 lymphocyte count was high for 9
(45%) of 20 patients tested and low for 3 (15%), with a me-
dian value of 953/4 (range, 134/AL-2,415/AL).
Discussion
We report 31 successive cases of symptomatic acute HIV
infection identified from May 1988 to April 1992 in Geneva.
This incidence can be compared to that of HIV seropositivity
in the same area [24], which has varied between 250 and 350
cases annually per 400,000 inhabitants for the period consid-
ered [24]. Thus, it appears that the great majority of cases
were not diagnosed during the acute stage. Several factors
could account for this: these patients may not have sought
medical attention or have had any symptoms, an inaccurate
diagnosis may have been made, or appropriate laboratory
tests such as those for detection of p24 antigen and HIV
antibody may not have been carried out. In the United
States, 40,000 new cases annually are forecast for the early
1990s, and it is assumed that the diagnosis of primary HIV
infection will be missed in a high proportion of them [25].
Symptomatic primary HIV infection has been previously
described in reports of isolated cases and of four series of
12-20 patients [2-4, 6], for whom a wide range of clinical
findings were described. These studies, except for one that
included six patients from other risk groups [6], focused ex-
clusively on populations of male homosexuals.
The majority of our patients were infected through sexual
intercourse, and a large proportion of them did not belong to
the predominant risk groups (homosexuals and IVDUs). Het-
erosexuals represented a high proportion (72% of the female
patients were infected by a male partner), a fact that is con-
sistent with the recent epidemic-related trend in Western
countries [26, 27]. IVDUs, who account for —50% of HIV-
seropositive persons locally, seem underrepresented in our
patient group, possibly as a result of two main factors [24].
First, these patients may not use our medical services as
readily as individuals from other risk groups. Second, be-
cause of new preventive measures, a sharp decrease in the
rate of seroconversions has occurred locally since 1988 in
this population [28]. The absence of mucosal ulcers in this
group and the performance of medical examinations that pos-
sibly were incomplete may have led to underdiagnosis as
well. In comparison with previous studies [2-4, 6], the pres-
ent study included a wider range of the different types of
patients who may be encountered in clinical practice, in
terms of both its size (31 patients) and patient population
(male-to-female ratio, 3.4:1; homosexual-to-heterosexual ra-
tio, 1.2:1).
The high rate of hospital admissions (42%) in comparison
with that in another report [4] could be explained on three
grounds. First, this was a hospital-based study, and the crite-
ria for inclusion included symptomatic infection. Second,
the diagnosis of acute HIV infection was initially missed for a
number of patients who were later referred to our hospital.
Third, clinical symptoms were often long-lasting and some-
times severe and therefore did not allow for outpatient care
(the mean duration of illness was 3 weeks) [2-4, 6, 7, 20].
Most of the relevant medical complaints were similar to
those reported in previous studies; they consisted mainly of
fever, skin rash, sore throat, and flulike illness and could be
considered unspecific [ 1-8]. The differential diagnosis at the
time of admission included common infectious illnesses such
as influenza, rubella, hepatitis, toxoplasmosis, syphilis, Ep-
stein-Barr virus infection, and cytomegalovirus infec-
tion [22].
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Diagnostic clues were found mainly when examining the
oral cavity (76.7%) and the skin (73%) in febrile patients
(70%). Ulcers and enanthema were the most frequent abnor-
malities of the oral mucosa [2, 3, 8, 9, 22, 29, 30]. These
ulcers were initially mistaken for herpes simplex lesions, al-
though the absence of vesicles and negative viral cultures
made this diagnosis unlikely [31]. They bore great clinical
resemblance to those encountered in cases of recurrent
aphthous stomatitis; however, in acute HIV infection, a
wider distribution and association with general symptoms
allowed this condition to be ruled out [32]. Oral ulcers in
viral illnesses such as cytomegalovirus infection and rubella
are unusual [33]. Ulcers that occur in cases of primary HIV
infection can be distinguished from those caused by Epstein-
Barr virus infection because the former are more widespread
and may involve the oral mucosa, gingiva, tongue, and soft
and hard portions of the palate [22, 34].
Skin involvement consisted predominantly of a maculopa-
pular rash and disseminated urticaria [3, 8, 10, 35]. No ro-
seolalike or vesicular exanthema like that previously de-
scribed [1, 2, 9, 36] was noted. Clinically, the maculopapular
rash could be differentiated from that associated with pityria-
sis rosea because of the involvement of the face, lower part of
the limbs, palms, and soles [37]. Furthermore, the presence
of mucosal erosive manifestations was helpful in the differ-
ential diagnosis. Syphilis was excluded by serological testing,
but in acute cases the association of macules and papules and
the atypical aspect of mucosal lesions help rule out this diag-
nosis [38].
Genital mucosal involvement like that seen in 35.5% of
our patients, particularly in the form of ulcers, should suggest
a possible diagnosis of primary HIV infection after other
causes of similar lesions, such as sexually transmitted dis-
eases, have been excluded [4, 29, 38, 39]. We did not find
any evidence of herpes simplex virus (type 1 or 2), Haemo-
philus ducreyi, or Treponema pallidum in our patients' le-
sions, but coinfection with Neisseria gonorrhoeae was noted
in two cases (6.5%).
As shown on figure 1, 52.4% of the patients with skin le-
sions also had oral or genital ulcerations or both. Conversely,
84.6% of the patients with mucosal involvement also had
skin lesions. This pattern of association between cutaneous
and mucosal signs is uncommon in most of the illnesses dis-
cussed above and appears to be relatively specific to primary
HIV infection. Whenever present, the triad of a maculopa-
pular rash and oral and genital ulcers should be considered
suggestive, as few other dermatologic or general illnesses
present in this way. One should be aware of the frequent
underreporting of oral and genital ulcerous lesions (table 2).
Gaines et al. [3] observed similar mucosal involvement in
seven (35%) of 20 male homosexuals and suggested that the
lesions might have appeared at the sites of viral inoculation
during sexual activity. This theory is supported by the fact
that when comparing the various risk groups, we found ero-
sive lesions only in patients with sexually acquired HIV in-
fection; however, this association did not reach statistical sig-
nificance (P = .052).
Abnormal pulmonary findings were observed on physical
examination of four patients. Febrile pneumonitis in associa-
tion with radiological signs of consolidation in two of these
patients, who reported recent drug abuse, was considered to
be of bacterial origin and was promptly treated with oral
antibiotics. The other two patients did not require any treat-
ment. Three case reports of pneumonitis in the setting of
primary HIV infection have been published; all three de-
scribe various degrees of hypoxemia and no identifiable
pathogen other than HIV [16, 40, 41]. Mechanical ventila-
tion was required for two of the three patients; one of them
was classified as having CD8 lymphocytic alveolitis. In pre-
vious studies, coughing appeared to be a frequent complaint;
Gaines et al. [3] described it in regard to six of 20 patients,
and Pedersen et al. [20], in regard to 19 of 46 patients. The
incidence and pathogenesis of lung involvement and the co-
factors that determine its type and extent are unknown, and
only prospective studies will identify them.
Esophagitis was detected in at least three patients. It was
considered to be of fungal origin and resolved rapidly follow-
ing appropriate therapy. Several case reports and one series
report [30, 42-49] have described this condition in the set-
ting of primary HIV infection and have suggested that severe
transient immunosuppression could be a determinant factor
[13, 46, 48]. Some patients with ulcerative esophagitis [49]
could be secondarily colonized by Candida organisms after
antibiotic therapy; in addition, the direct role of HIV and of
other viruses in this condition cannot be excluded [47]. In
our series of patients, acute coinfection with CMV was ruled
out by serological testing (data not shown).
Only two patients presented with severe CNS manifesta-
tions, which resolved spontaneously; this prevalence is in
contrast with the great variety of neurological syndromes de-
scribed in several reports [3, 6, 10, 50-54].
None of the laboratory results, except those for HIV serol-
ogy, are specific. However, the hematologic parameters asso-
ciated with the clinical symptoms and signs might point to-
ward acute HIV infection. Twenty-one (91.3%) of the 23
patients for whom such data were available had _ 1 CBC-re-
lated abnormality; although thrombocytopenia [55] was the
most frequent one, anemia (a finding not previously reported
[22]) occurred in up to one-quarter of the patients. Hemoglo-
bin values, however, were never <114 g/L. Other abnormali-
ties, in particular the decrease from normal leukocyte and
neutrophil counts and the increase from normal band form
counts, may all be consistent with various viral, bacterial, or
fungal infections when associated with fever. However,
when cultures remain negative for such pathogens, the diag-
nosis of primary HIV infection should be entertained.
The most specific laboratory tool was the search for p24
antigen, which was detected in 79% of patients. Few system-
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atic laboratory data are available about the rate of detectabil-
ity of antigenemia in symptomatic seroconverting patients.
Pedersen et al. [20] detected p24 antigen in 22 (44%) of 50
patients; Sinicco et al. [6] detected antigenemia in nine
(75%) of 12 symptomatic patients. Von Sydow et al. [56]
detected antigenemia in all 12 patients tested during the first
week following the onset of symptoms, but the rate of p24
antigen recovery decreased subsequently. In the present se-
ries, the use of screening tests for both p24 antigen and HIV
antibody allowed for diagnosis of HIV infection in 92% of
cases. The "window effect" [56] may explain the negative
results of both tests for two patients. Therefore, in most in-
stances, when clinical suspicion is high, both tests should be
performed and repeated.
The results of analysis of the lymphocyte subsets were
consistent with those in previous reports [57, 58]. The diag-
nostic value of such an analysis remains low, but its use at
least once during the acute stage can explain some of the
unusual clinical presentations associated with severe immu-
nosuppression, such as candidal esophagitis [42-49].
Finally, acute coinfection with other common infectious
agents appears to be a rare event (N. gonorrhoeae-related ure-
thritis is the exception). We have diagnosed simultaneous
hepatitis B virus infection in only one of 30 patients who
repeatedly underwent serological testing for acute hepatitis
A, B, C, and D and acute cytomegalovirus infections (data
not shown). This is consistent with previous findings [4, 20].
In conclusion, primary HIV infection can be a debilitating
disease that may require hospitalization for diagnosis and
treatment. As the infection spreads into the heterosexual pop-
ulation of Western countries, its diagnosis may be missed
without a high degree of clinical suspicion. Dermatologic
signs that include involvement of both skin and mucosae in
febrile patients should prompt rapid testing for p24 antigen
and HIV antibodies for the purpose of confirming clinical
suspicions.
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